Rodriguez-Antona C - Search Results

1

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Ingelman-Sundberg M, et al. Pharmacol Ther. 2007 Dec;116(3):496-526. doi: 10.1016/j.pharmthera.2007.09.004. Epub 2007 Oct 9. Pharmacol Ther. 2007. PMID: 18001838 Review.

2

A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.

Pitarque M, von Richter O, Rodríguez-Antona C, Wang J, Oscarson M, Ingelman-Sundberg M. Pitarque M, et al. Hum Mutat. 2004 Mar;23(3):258-66. doi: 10.1002/humu.20002. Hum Mutat. 2004. PMID: 14974084

3

Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6).

von Richter O, Pitarque M, Rodríguez-Antona C, Testa A, Mantovani R, Oscarson M, Ingelman-Sundberg M. von Richter O, et al. Pharmacogenetics. 2004 Jun;14(6):369-79. doi: 10.1097/00008571-200406000-00006. Pharmacogenetics. 2004. PMID: 15247629

4

New approaches and applications in chemical biology.

Gomez A, Ingelman-Sundberg M, Johansson I, Karlgren M, Rodriguez-Antona C, Sim SC. Gomez A, et al. Drug News Perspect. 2004 Nov;17(9):594-605. Drug News Perspect. 2004. PMID: 15645017

5

Transcriptional regulation of the human CYP2A6 gene.

Pitarque M, Rodríguez-Antona C, Oscarson M, Ingelman-Sundberg M. Pitarque M, et al. J Pharmacol Exp Ther. 2005 May;313(2):814-22. doi: 10.1124/jpet.104.081570. Epub 2005 Jan 25. J Pharmacol Exp Ther. 2005. PMID: 15671201

6

Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Rodríguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Clin Pharmacol Ther. 2005 Apr;77(4):259-70. doi: 10.1016/j.clpt.2004.11.003. Clin Pharmacol Ther. 2005. PMID: 15903124

7

A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.

Rodriguez-Antona C, Axelson M, Otter C, Rane A, Ingelman-Sundberg M. Rodriguez-Antona C, et al. J Biol Chem. 2005 Aug 5;280(31):28324-31. doi: 10.1074/jbc.M502309200. Epub 2005 Jun 2. J Biol Chem. 2005. PMID: 15937338

8

Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.

Ingelman-Sundberg M, Rodriguez-Antona C. Ingelman-Sundberg M, et al. Philos Trans R Soc Lond B Biol Sci. 2005 Aug 29;360(1460):1563-70. doi: 10.1098/rstb.2005.1685. Philos Trans R Soc Lond B Biol Sci. 2005. PMID: 16096104 Free PMC article. Review.

9

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles.

Rodríguez-Antona C, Sayi JG, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Biochem Biophys Res Commun. 2005 Dec 9;338(1):299-305. doi: 10.1016/j.bbrc.2005.09.020. Epub 2005 Sep 13. Biochem Biophys Res Commun. 2005. PMID: 16171783

10

Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.

Karlgren M, Gomez A, Stark K, Svärd J, Rodriguez-Antona C, Oliw E, Bernal ML, Ramón y Cajal S, Johansson I, Ingelman-Sundberg M. Karlgren M, et al. Biochem Biophys Res Commun. 2006 Mar 10;341(2):451-8. doi: 10.1016/j.bbrc.2005.12.200. Epub 2006 Jan 11. Biochem Biophys Res Commun. 2006. PMID: 16426568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results